scholarly journals 2016 Presidential Election - The Winners and Losers in the Health Care Industry

2019 ◽  
Vol 9 (4) ◽  
pp. 260
Author(s):  
Afua Agyekum ◽  
Sharon Finney ◽  
Ayishat Omar ◽  
Alex P Tang
Keyword(s):  
Health Care ◽  
Health Insurance ◽  
Stock Returns ◽  
Event Study ◽  
Presidential Election ◽  
Abnormal Returns ◽  
Health Care Industry ◽  
Biological Products ◽  
Care Industry ◽  
Study Results

The 2016 presidential election had important implications for the country’s health care policies. In this study, we examine the health care industry stock returns associated with the 2016 presidential campaign. We use both market model and seemingly unrelated regression (SUR) methodologies to estimate abnormal stock returns of each health care sector associated with each event. Our results are robust and mostly consistent with our arguments. The regression analysis further augments our event study results. We find that, during the pre-election period, the Biological Products, Health Insurance, and Major Pharmaceuticals all suffer significantly negative cumulative average abnormal returns (CAARs). The Hospital/Nursing Management and Medical/Dental Instruments fare reasonably well. Our interpretation is that the market takes a dim view on the Biological Products, Health Insurance, and Major Pharmaceuticals sectors when the consensus is that Clinton would win the election. When the election is over, the fortune reverses for the Biological Products and Major Pharmaceuticals. It continues when President Trump meets with the health care industry CEOs. The regression results further confirm our event study results. Our study shows that the 2016 election has a significant impact on the affected industry and the firms in the industry. However, even in the same broad industry, sectors/firms fare differently. Our study shows that it is important to identify the winning and losing sectors and examine the impact of an election on various sectors in a detailed and refined way.

scholarly journals Change, Consolidation, and Competition in Health Care Markets

1999 ◽  
Vol 13 (1) ◽  
pp. 141-164 ◽  
Author(s):  
Martin Gaynor ◽  
Deborah Haas-Wilson
Keyword(s):  
Health Care ◽  
Public Policy ◽  
Health Insurance ◽  
Health Care Industry ◽  
Health Care Markets ◽  
Hospital Services ◽  
Physician Services ◽  
Care Industry

In this paper, the authors summarize the nature of the changes in the structure of the health-care industry. They focus on the markets for health insurance, hospital services, and physician services. They discuss the potential implications of the restructuring of the health care industry for competition, efficiency, and public policy. As will become apparent, this area offers a number of intriguing questions.

scholarly journals Acquisitions And Common Stock Returns In The Health Care Industry: 1982-1985

2011 ◽  
Vol 5 (1) ◽  
pp. 59 ◽  
Author(s):  
Rose Rubin ◽  
Imre Karafaith ◽  
Kenneth L. Smith
Keyword(s):  
Health Care ◽  
Stock Returns ◽  
Health Care Industry ◽  
Competitive Environment ◽  
Common Stock ◽  
Excess Returns ◽  
Care Industry ◽  
Specific Event ◽  
Acquiring Firms ◽  
The Difference

Employing a methodology commonly used to determine the movement of stock returns around a specific event, we examined the movement of common stock returns of acquiring firms in the health care industry for three periods, 1982-1983, 1984, and 1985. We find that in the 1982-1983 period, investors could expect negative excess returns from holding tock in acquiring firms in the health care industry. In contrast, for the 1984 and 1985 periods we find no evidence of excel returns for investors. The difference between the two periods, we believe, is due to the more competitive environment which existed in the industry in the latter two periods.

scholarly journals What Does Health Reform Mean for the Health Care Industry? Evidence from the Massachusetts Special Senate Election

2013 ◽  
Vol 5 (3) ◽  
pp. 1-29 ◽  
Author(s):  
Mohamad M Al-Ississ ◽  
Nolan H Miller
Keyword(s):  
Health Care ◽  
Managed Care ◽  
Health Reform ◽  
Abnormal Returns ◽  
Health Care Industry ◽  
Health Care Facilities ◽  
Care Industry ◽  
Reform Legislation ◽  
Us Senate ◽  
The Impact

We exploit the surprise election of Republican Scott Brown to the US Senate to evaluate the market's assessment of the impact of the recent US health reform legislation on the health care industry. We find that Brown's election was associated with abnormal returns of 2.1 percent and 6 percent for investments in the health care sector overall and managed care firms, respectively. Investments in the pharmaceutical sector experienced abnormal returns of 2.8 percent, while health care facilities (e.g., hospitals) experienced abnormal losses of 3.5 percent. Firms involved with Medicare Advantage benefitted more, while those involved with Medicaid Managed Care benefitted less from the election. (JEL D72, H51, I11, I18)

scholarly journals Market Reaction to Health Care Law: An Event Study

2013 ◽  
Vol 3 (1) ◽  
pp. 108 ◽  
Author(s):  
Musab Ababneh ◽  
Alex Tang
Keyword(s):  
Health Care ◽  
Health Insurance ◽  
Event Study ◽  
Generic Drug ◽  
Abnormal Returns ◽  
Insurance Companies ◽  
Brand Name ◽  
Negative Effect ◽  
Health Insurance Companies ◽  
Health Care Law

We investigate the effect of the U.S. Supreme Court’s decision to uphold President Obama’s health care reform (Patient Protection and Affordable Care Act), and other reform-related events, on the stocks of impacted firms. More specifically, we use an event study methodology to compute cumulative average abnormal returns (CAARs) for health insurance companies, hospitals, brand-name drug makers, and generic drug makers. Overall, we find that the law has a negative effect on health insurance companies, and on generic drug makers. On the other hand, it has a positive effect on hospitals and on brand-name drug makers.

Reimbursement for Nursing Services: Issues and Trends

1980 ◽  
Vol 1 (4) ◽  
pp. 1-4
Author(s):  
Nancy Baker
Keyword(s):  
Health Care ◽  
Health Insurance ◽  
Health Care Industry ◽  
Care Physician ◽  
List Type ◽  
Type Number ◽  
Physician Services ◽  
Hospital Administrators ◽  
Care Industry ◽  
Nursing Services

Americans have long wanted a health care system that is accessible, comprehensive and affordable. Our failure to accomplish these goals has resulted in a resurgence of interest in national health insurance as a mechanism for increasing access, expanding the scope of services, and controlling costs.Unfortunately, the health care industry (which is really a sick care industry) has fostered dependence on the two most expensive components of care: physician services and hospitalization. This situation has evolved from several historical themes, three of which threaten to perpetuate our inflationary system and prevent reimbursement for non-physicians:1.failure to distinguish between medical care and health care2.control of the industry by physicians and hospital administrators3.lack of recognition for and undervaluing of the services of nursesAll of these factors have reduced the health options for consumers and have been demoralizing for nurses. This discussion will focus on various ways these issues impact upon the contributions nurses can make.

scholarly journals Exploring the Social Networks’ Use in the Health-Care Industry: A Multi-Level Analysis

2021 ◽  
Vol 18 (14) ◽  
pp. 7295
Author(s):  
Tommasina Pianese ◽  
Patrizia Belfiore
Keyword(s):  
Health Care ◽  
Social Networks ◽  
Health Care Providers ◽  
Health Care Industry ◽  
Future Research ◽  
Great Level ◽  
Care Providers ◽  
Care Industry ◽  
Multi Level ◽  
Video And Audio

The application of social networks in the health domain has become increasingly prevalent. They are web-based technologies which bring together a group of people and health-care providers having in common health-related interests, who share text, image, video and audio contents and interact with each other. This explains the increasing amount of attention paid to this topic by researchers who have investigated a variety of issues dealing with the specific applications in the health-care industry. The aim of this study is to systematize this fragmented body of literature, and provide a comprehensive and multi-level overview of the studies that has been carried out to date on social network uses in healthcare, taking into account the great level of diversity that characterizes this industry. To this end, we conduct a scoping review enabling to identify the major research streams, whose aggregate knowledge are discussed according to three levels of analysis that reflect the viewpoints of the major actors using social networks for health-care purposes, i.e., governments, health-care providers (including health-care organizations and professionals) and social networks’ users (including ill patients and general public). We conclude by proposing directions for future research.

Antitrust Implications of Health Planning: National Gerimedical Hospital and Gerontology Center v. Blue Cross of Kansas City

1982 ◽  
Vol 8 (3) ◽  
pp. 321-348
Author(s):  
Judy B. Chase
Keyword(s):  
Health Care ◽  
Kansas City ◽  
Health Planning ◽  
United States Supreme Court ◽  
Health Care Industry ◽  
The United States ◽  
United States Supreme ◽  
Planning Activity ◽  
Care Industry ◽  
Antitrust Laws

AbstractIn National Gerimedical Hospital and Gerontology Center v. Blue Cross of Kansas City, the United States Supreme Court held that there is no blanket exemption from antitrust laws for health planning activities.‘The Court also held that no specific immunity can be granted where the challenged health planning activity is not undertaken pursuant to a federal regulatory scheme. This Comment reviews the Court’s decision and concludes that the Court correctly determined that the challenged activities did not qualify for an exemption. The Comment also examines the implications of the Court's statement that, where Congress has manifested a belief that competition is ineffective in the health care industry, application of the antitrust laws should be modified. The Comment recommends that an intermediate review standard such as the “presumptive, incentive modifying approach” should be used by future courts in deciding whether the ineffectiveness of competition in a given area of health planning activity warrants immunity from antitrust scrutiny.

Sign in / Sign up

Export Citation Format

Share Document